Enables dipeptide transmembrane transporter activity. Involved in several processes, including chemical homeostasis; nitrogen compound transport; and regulation of signal transduction. Located in apical plasma membrane. Expressed in intestine. Used to study obesity. Is an ortholog of human SLC15A1 (solute carrier family 15 member 1).
Enables dipeptide transmembrane transporter activity and proton channel activity. Involved in dipeptide transport and proton transmembrane transport. Predicted to be located in membrane. Expressed in AVAL; AVAR; pharynx; and touch receptor neurons. Is an ortholog of human SLC15A1 (solute carrier family 15 member 1) and SLC15A2 (solute carrier family 15 member 2).
Predicted to enable dipeptide transmembrane transporter activity. Involved in IRE1-mediated unfolded protein response. Predicted to be located in membrane. Expressed in anal depressor muscle; anal sphincter muscle; pharyngeal muscle cell; and vulval muscle. Is an ortholog of human SLC15A1 (solute carrier family 15 member 1).
Predicted to enable aminopeptidase activity and epoxide hydrolase activity. Involved in negative regulation of fatty acid transport; regulation of lipid storage; and regulation of peptide transport. Predicted to be located in cytosol. Is an ortholog of human LTA4H (leukotriene A4 hydrolase).
Involved in negative regulation of fatty acid transport; regulation of lipid storage; and regulation of peptide transport. Predicted to be located in membrane. Expressed in excretory cell; hypodermis; intestinal cell; and pharyngeal muscle cell.
Predicted to enable RNA polymerase II CTD heptapeptide repeat phosphatase activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Human ortholog(s) of this gene implicated in several diseases, including carcinoma (multiple); endometrial cancer; and primary autosomal recessive microcephaly 1. Is an ortholog of human MCPH1 (microcephalin 1).